| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | regorafenib | FAERS: 8 | US FAERS | |
| 2 | Zoledronic Acid | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance OFFSIDES US FAERS | |
| 3 | Capecitabine | FAERS: 2 | US FAERS | |
| 4 | Codeine | FAERS: 2 | US FAERS | |
| 5 | Imatinib Mesylate | FAERS: 2 | US FAERS | |
| 6 | Lenalidomide | FAERS: 2 | US FAERS | |
| 7 | Teriparatide | FAERS: 2 | US FAERS | |
| 8 | Breo Ellipta | FAERS: 1 | US FAERS | |
| 9 | Buprenorphine | FAERS: 1 | US FAERS | |
| 10 | Hydroxyurea | FAERS: 1 | US FAERS | |
| 11 | Ibandronic Acid | FAERS: 1 | OFFSIDES US FAERS | |
| 12 | Irinotecan | FAERS: 1 | US FAERS | |
| 13 | Mycophenolic Acid | FAERS: 1 | US FAERS | |
| 14 | Quetiapine Fumarate | FAERS: 1 | US FAERS | |
| 15 | Rivaroxaban | FAERS: 1 | US FAERS | |
| 16 | Sildenafil Citrate | FAERS: 1 | US FAERS | |
| 17 | Sorafenib | FAERS: 1 | US FAERS | |
| 18 | Venlafaxine Hydrochloride | FAERS: 1 | US FAERS | |
| 19 | carbidopa, levodopa drug combination | FAERS: 1 | US FAERS | |
| 20 | dabrafenib | FAERS: 1 | US FAERS | |
| 21 | olaparib | FAERS: 1 | US FAERS | |
| 22 | pazopanib | FAERS: 1 | US FAERS | |
| 23 | Chlorhexidine | OFFSIDES | ||
| 24 | D-Galactosamine | OFFSIDES | ||
| 25 | Estrogens, Conjugated (USP) | OFFSIDES | ||
| 26 | Famotidine | OFFSIDES | ||
| 27 | Fluorouracil | OFFSIDES | ||
| 28 | Gatifloxacin | OFFSIDES | ||
| 29 | Leflunomide | OFFSIDES | ||
| 30 | Leucovorin | OFFSIDES | ||
| 31 | Metronidazole | OFFSIDES | ||
| 32 | Octreotide | OFFSIDES | ||
| 33 | Pamidronate | OFFSIDES | ||
| 34 | Xipamide | OFFSIDES | ||
| 35 | bicalutamide | OFFSIDES | ||
| 36 | chlorhexidine gluconate | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.